ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

AZN Astrazeneca Plc

10,474.00
412.00 (4.09%)
22 Nov 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Astrazeneca Plc LSE:AZN London Ordinary Share GB0009895292 ORD SHS $0.25
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  412.00 4.09% 10,474.00 10,502.00 10,504.00 10,548.00 10,140.00 10,184.00 2,847,206 16:35:05
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
Pharmaceutical Preparations 45.81B 5.96B 3.8412 27.35 155.99B
Astrazeneca Plc is listed in the Pharmaceutical Preparations sector of the London Stock Exchange with ticker AZN. The last closing price for Astrazeneca was 10,062p. Over the last year, Astrazeneca shares have traded in a share price range of 9,461.00p to 13,338.00p.

Astrazeneca currently has 1,550,294,658 shares in issue. The market capitalisation of Astrazeneca is £155.99 billion. Astrazeneca has a price to earnings ratio (PE ratio) of 27.35.

Astrazeneca Share Discussion Threads

Showing 6051 to 6074 of 6350 messages
Chat Pages: 254  253  252  251  250  249  248  247  246  245  244  243  Older
DateSubjectAuthorDiscuss
22/12/2023
07:22
Great RNS!! should see at least 10700 today and that is still under the 200 DMA.
turvart
16/12/2023
16:53
A Astra Covid vaccine is causing serious illness in some cases. Is this bad news a cause for concern?, anybody know?
hopefuldave
15/12/2023
15:44
Hopefully a better year for the share price in 2024.
smcni1968
15/12/2023
14:41
Telegraph tip

Questor Wealth Preserver: as one of our holdings looks likely to be taken over, we are replacing it with a high-quality pharmaceutical stock





Article:

philanderer
14/12/2023
16:43
Non Exec director buy


487 at £101.8956

philanderer
08/12/2023
13:48
9976 in, seems a good time short bet to me?

11K?

dudishes
07/12/2023
17:21
Was expecting they would be taking over LumiraDx LMDX after partnership deal
hxxps://www.pharmashots.com/16262/lumiradx-collaborates-with-astrazeneca-and-everton-to-establish
Turns out it may be Roche RHHBY

tmas
05/12/2023
17:50
AZN now well below the 200 & 50 day moving average, the 200 day MA is approx 11000 area so this is a steal IMO with all the future developments in phase 11 & 111 trials. One aspect I also like is the fact AZN do not stand still and get complacent the company is always striving to get bigger and make regular acquisitions.

AZN was my very first stock I purchased when I was a complete newbie back in 2001 and I paid £17.50 a share back then, look at the growth of this immense stock of which I'm sure will get to £130 by the end of 2024 IMO, AZN was in my portfolio in 2001 at 1750 and still are and has been my best performing stock, just wished I'd have bought more and left them alone re-investing the dividends along the way.

Strong buy IMO.

turvart
05/12/2023
10:33
JPMorgan cuts AstraZeneca price target to 13,000 (14,000) pence - 'overweight'
philanderer
27/11/2023
23:09
I have placed a limit order to buy at 95. I may pull it in favour of something paying a better dividend. there is plenty to chose from at present. The important thing in this market is not to chase. Let the price come to us.
1knocker
27/11/2023
19:22
Sharecast market report..

"....Pharmaceutical giant AstraZeneca was off 1.73% after a broker note from Jefferies, which lowered its price target on the shares from 13,000p to 12,500p."


edit:

AstraZeneca sank after the City broker Jefferies stressed it needed to provide more clarity on its forecasts and cut its target price to 12500p from 13000p.

DMail market report

philanderer
27/11/2023
16:20
One week on and it's really struggling again to hold £100 level.
philanderer
22/11/2023
14:19
Questor tip 'Buy'


'Elephants don’t gallop – except for AstraZeneca'

Questor share tip: the company’s growth rate and valuation suggest further capital gains are ahead

philanderer
20/11/2023
22:48
PER still looks very toppy, a lot of scope for disappointment there.
f880gna
20/11/2023
12:27
Struggling to keep above £100
philanderer
17/11/2023
18:41
Greg B. Yes. They will divest China but whether that is a sale or separate listing, I don't know.

AZ China is 15% of AZ TO so its relevant.

mr euro
17/11/2023
11:24
Fading already- maybe 2024 will be a better year. I'm sure part of the problem is that the incremental $$$$ is going into Eli Lilly and Novo Nordisk so Astra and others are being ignored
smcni1968
17/11/2023
10:49
Some good news...

In London’s FTSE 100, AstraZeneca rose 1.5%.

The pharmaceutical firm said its Truqap treatment for patients with advanced hormone receptor positive breast cancer, in combination with Faslodex, has been approved by the US Food & Drug Administration.

This follows the results from its CapItello-291 phase 3 trial published earlier this year, which showed reduced risk of disease progression or death by 50% compared to Faslodex alone.

philanderer
17/11/2023
08:24
Do you have any more up to date info?
gregb
17/11/2023
07:29
I don't own AZ so have no interest.

hxxps://www.fiercepharma.com/pharma/misinformation-astrazenecas-china-head-refutes-spinoff-report

Not sure how a sale would effect the share price, be it a sale or standalone listing out of HK? One would assume this would be positive.

mr euro
15/11/2023
17:07
A failure is a failure, simples!
dudishes
15/11/2023
16:26
Blackhorse23 filtered.
faz
15/11/2023
16:03
Could certainly do with some good news here. Hitting the 2023 lows now 😳
philanderer
15/11/2023
10:27
Money moving to APH , excellent healthcare dividend company
blackhorse23
Chat Pages: 254  253  252  251  250  249  248  247  246  245  244  243  Older

Your Recent History

Delayed Upgrade Clock